Stryker (SYK) Stock: Charts & Financials

Stryker Corporation (SYK)SYKStryker Corporation

About Stryker Corporation

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Portage, MI

56,000 employees

www.stryker.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Kevin A. Lobo

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	25.84B	6.59B	6.02B	7.17B	6.06B	6.02B	5.87B	6.44B	5.49B
Cost of Goods Sold	9.00B	2.09B	2.21B	2.49B	2.21B	2.27B	2.19B	2.45B	2.10B
Gross Profit	16.84B	4.50B	3.81B	4.68B	3.85B	3.75B	3.68B	3.99B	3.39B
Gross Profit Margin	65.2%	68.3%	63.3%	65.2%	63.6%	62.3%	62.7%	62.0%	61.8%
Total Operating Expenses	10.97B	2.66B	2.87B	2.72B	2.72B	2.39B	2.50B	2.33B	2.19B
Research & Development	1.66B	434.00M	413.00M	401.00M	410.00M	396.00M	393.00M	342.00M	364.00M
Selling, General & Administrative	8.78B	2.23B	2.28B	2.23B	2.04B	1.99B	2.11B	1.98B	1.82B
Operating Income (EBIT)	5.69B	1.66B	936.00M	1.96B	1.14B	1.36B	1.18B	1.66B	1.21B
Operating Margin	22.0%	25.2%	15.5%	27.3%	18.7%	22.6%	20.1%	25.8%	22.0%
Income Before Tax (EBT)	5.15B	1.56B	850.00M	1.71B	1.03B	1.02B	764.00M	528.00M	1.04B
Interest Income	28.00M	N/A	N/A	N/A	28.00M	24.00M	38.00M	47.00M	30.00M
Interest Expense	686.00M	N/A	148.00M	381.00M	157.00M	159.00M	N/A	N/A	N/A
Other Income/Expense	-543.00M	-95.00M	-86.00M	-256.00M	-106.00M	-345.00M	-415.00M	-1.14B	-165.00M
Net Income	3.73B	1.28B	745.00M	849.00M	859.00M	884.00M	654.00M	546.00M	834.00M
Income Tax Expense	1.42B	288.00M	105.00M	856.00M	170.00M	132.00M	110.00M	-18.00M	209.00M
Net Profit Margin	14.4%	19.4%	12.4%	11.8%	14.2%	14.7%	11.1%	8.5%	15.2%
EBITDA	6.64B	1.66B	1.24B	2.28B	1.47B	1.66B	1.45B	1.93B	1.48B
EBITDA Margin	25.7%	25.2%	20.5%	31.8%	24.3%	27.5%	24.7%	29.9%	26.9%
Depreciation & Amortization	950.00M	0.00	300.00M	316.00M	334.00M	296.00M	272.00M	264.00M	268.00M
EPS Basic	9.73	3.32	1.95	2.21	2.25	2.32	1.71	1.43	2.19
EPS Diluted	9.65	3.30	1.93	2.20	2.22	2.29	1.69	1.41	2.16
Shares Outstanding	383.50M	383.50M	382.90M	382.50M	382.40M	382.20M	381.70M	381.00M	381.10M
Diluted Shares Outstanding	386.00M	386.00M	386.50M	386.50M	386.70M	386.40M	386.40M	386.10M	385.60M

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

25.84B

6.59B

6.02B

7.17B

6.06B

6.02B

5.87B

6.44B

5.49B

Cost of Goods Sold

9.00B

2.09B

2.21B

2.49B

2.21B

2.27B

2.19B

2.45B

2.10B

Gross Profit

16.84B

4.50B

3.81B

4.68B

3.85B

3.75B

3.68B

3.99B

3.39B

Gross Profit Margin

65.2%

68.3%

63.3%

65.2%

63.6%

62.3%

62.7%

62.0%

61.8%

Total Operating Expenses

10.97B

2.66B

2.87B

2.72B

2.39B

2.50B

2.33B

2.19B

Research & Development

1.66B

434.00M

413.00M

401.00M

410.00M

396.00M

393.00M

342.00M

364.00M

Selling, General & Administrative

8.78B

2.23B

2.28B

2.23B

2.04B

1.99B

2.11B

1.98B

1.82B

Operating Income (EBIT)

5.69B

1.66B

936.00M

1.96B

1.14B

1.36B

1.18B

1.66B

1.21B

Operating Margin

22.0%

25.2%

15.5%

27.3%

18.7%

22.6%

20.1%

25.8%

22.0%

Income Before Tax (EBT)

5.15B

1.56B

850.00M

1.71B

1.03B

1.02B

764.00M

528.00M

1.04B

Interest Income

28.00M

N/A

28.00M

24.00M

38.00M

47.00M

30.00M

Interest Expense

686.00M

N/A

148.00M

381.00M

157.00M

159.00M

N/A

Other Income/Expense

-543.00M

-95.00M

-86.00M

-256.00M

-106.00M

-345.00M

-415.00M

-1.14B

-165.00M

Net Income

3.73B

1.28B

745.00M

849.00M

859.00M

884.00M

654.00M

546.00M

834.00M

Income Tax Expense

1.42B

288.00M

105.00M

856.00M

170.00M

132.00M

110.00M

-18.00M

209.00M

Net Profit Margin

14.4%

19.4%

12.4%

11.8%

14.2%

14.7%

11.1%

8.5%

15.2%

EBITDA

6.64B

1.66B

1.24B

2.28B

1.47B

1.66B

1.45B

1.93B

1.48B

EBITDA Margin

25.7%

25.2%

20.5%

31.8%

24.3%

27.5%

24.7%

29.9%

26.9%

Depreciation & Amortization

950.00M

0.00

300.00M

316.00M

334.00M

296.00M

272.00M

264.00M

268.00M

EPS Basic

9.73

3.32

1.95

2.21

2.25

2.32

1.71

1.43

2.19

EPS Diluted

9.65

3.30

1.93

2.20

2.22

2.29

1.69

1.41

2.16

Shares Outstanding

383.50M

382.90M

382.50M

382.40M

382.20M

381.70M

381.00M

381.10M

Diluted Shares Outstanding

386.00M

386.50M

386.70M

386.40M

386.10M

385.60M

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	25.12B	22.59B	20.50B	18.45B	17.11B	14.35B	14.88B	13.60B
Cost of Goods Sold	9.05B	8.62B	8.00B	7.41B	6.40B	5.60B	5.50B	5.00B
Gross Profit	16.07B	13.98B	12.49B	11.04B	10.71B	8.75B	9.38B	8.60B
Gross Profit Margin	64.0%	61.9%	61.0%	59.8%	62.6%	61.0%	63.0%	63.2%
Total Operating Expenses	11.18B	8.92B	8.21B	7.31B	6.95B	5.72B	5.99B	5.50B
Research & Development	1.58B	1.41B	1.29B	1.23B	1.13B	905.00M	971.00M	862.00M
Selling, General & Administrative	8.65B	7.50B	6.92B	6.08B	5.81B	4.82B	5.02B	4.63B
Operating Income (EBIT)	4.89B	5.06B	4.28B	3.73B	3.76B	3.03B	3.39B	3.10B
Operating Margin	19.5%	22.4%	20.9%	20.2%	22.0%	21.1%	22.8%	22.8%
Income Before Tax (EBT)	4.51B	3.49B	3.67B	2.68B	2.28B	1.95B	2.56B	2.36B
Interest Income	121.00M	139.00M	75.00M	94.00M	68.00M	102.00M	155.00M	119.00M
Interest Expense	607.00M	396.00M	356.00M	337.00M	337.00M	315.00M	287.00M	264.00M
Other Income/Expense	-375.00M	-1.57B	-608.00M	-1.05B	-1.48B	-1.07B	-826.00M	-748.00M
Net Income	3.25B	2.99B	3.17B	2.36B	1.99B	1.60B	2.08B	3.55B
Income Tax Expense	1.27B	499.00M	508.00M	325.00M	287.00M	355.00M	479.00M	-1.20B
Net Profit Margin	12.9%	13.2%	15.4%	12.8%	11.7%	11.1%	14.0%	26.1%
EBITDA	6.08B	6.11B	5.31B	4.73B	4.75B	3.84B	4.17B	3.83B
EBITDA Margin	24.2%	27.0%	25.9%	25.6%	27.8%	26.8%	28.0%	28.1%
Depreciation & Amortization	1.19B	1.05B	1.03B	998.00M	990.00M	812.00M	778.00M	723.00M
EPS Basic	8.49	7.86	8.34	6.23	5.29	4.26	5.57	9.50
EPS Diluted	8.40	7.76	8.25	6.17	5.22	4.20	5.48	9.34
Shares Outstanding	382.20M	381.00M	379.60M	378.20M	377.00M	375.50M	374.00M	374.10M
Diluted Shares Outstanding	382.20M	385.60M	383.70M	382.20M	382.30M	380.30M	379.90M	380.30M

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Revenue

25.12B

22.59B

20.50B

18.45B

17.11B

14.35B

14.88B

13.60B

Cost of Goods Sold

9.05B

8.62B

8.00B

7.41B

6.40B

5.60B

5.50B

5.00B

Gross Profit

16.07B

13.98B

12.49B

11.04B

10.71B

8.75B

9.38B

8.60B

Gross Profit Margin

64.0%

61.9%

61.0%

59.8%

62.6%

61.0%

63.0%

63.2%

Total Operating Expenses

11.18B

8.92B

8.21B

7.31B

6.95B

5.72B

5.99B

5.50B

Research & Development

1.58B

1.41B

1.29B

1.23B

1.13B

905.00M

971.00M

862.00M

Selling, General & Administrative

8.65B

7.50B

6.92B

6.08B

5.81B

4.82B

5.02B

4.63B

Operating Income (EBIT)

4.89B

5.06B

4.28B

3.73B

3.76B

3.03B

3.39B

3.10B

Operating Margin

19.5%

22.4%

20.9%

20.2%

22.0%

21.1%

22.8%

Income Before Tax (EBT)

4.51B

3.49B

3.67B

2.68B

2.28B

1.95B

2.56B

2.36B

Interest Income

121.00M

139.00M

75.00M

94.00M

68.00M

102.00M

155.00M

119.00M

Interest Expense

607.00M

396.00M

356.00M

337.00M

315.00M

287.00M

264.00M

Other Income/Expense

-375.00M

-1.57B

-608.00M

-1.05B

-1.48B

-1.07B

-826.00M

-748.00M

Net Income

3.25B

2.99B

3.17B

2.36B

1.99B

1.60B

2.08B

3.55B

Income Tax Expense

1.27B

499.00M

508.00M

325.00M

287.00M

355.00M

479.00M

-1.20B

Net Profit Margin

12.9%

13.2%

15.4%

12.8%

11.7%

11.1%

14.0%

26.1%

EBITDA

6.08B

6.11B

5.31B

4.73B

4.75B

3.84B

4.17B

3.83B

EBITDA Margin

24.2%

27.0%

25.9%

25.6%

27.8%

26.8%

28.0%

28.1%

Depreciation & Amortization

1.19B

1.05B

1.03B

998.00M

990.00M

812.00M

778.00M

723.00M

EPS Basic

8.49

7.86

8.34

6.23

5.29

4.26

5.57

9.50

EPS Diluted

8.40

7.76

8.25

6.17

5.22

4.20

5.48

9.34

Shares Outstanding

382.20M

381.00M

379.60M

378.20M

377.00M

375.50M

374.00M

374.10M

Diluted Shares Outstanding

382.20M

385.60M

383.70M

382.20M

382.30M

380.30M

379.90M

380.30M

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)